Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GSK divests two travel vaccines to Bavarian Nordic

Executive Summary

Bavarian Nordic AS acquired global manufacturing and commercialization rights to GlaxoSmithKline PLC’s travel vaccines Rabipur/RabAvert and Encepur for up to $888.7mm (€796mm).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing
    • Product Purchase

Related Companies

UsernamePublicRestriction

Register